Search

Rameshbabu B Boga

from Atlanta, GA
Age ~63

Rameshbabu Boga Phones & Addresses

  • Atlanta, GA
  • 10030 Carrington Cv, Alpharetta, GA 30022
  • Suwanee, GA
  • 1214 Hemingway Ln, Roswell, GA 30075
  • 16302 El Camino Real #3223, Houston, TX 77062
  • Milwaukee, WI
  • Ann Arbor, MI

Work

Company: Bogar laboratories Jul 1, 2007 Position: Founder and president

Education

School / High School: Kyoto University 1988 to 1990 Specialities: Biology, Organic Chemistry

Skills

Organic Chemistry • Technology Scouting • Technology Transfer • Commercialization • R&D • Biochemistry • Biotechnology • Drug Discovery • Medicinal Chemistry • Protein Purification • Pharmaceutical Industry • Elisa • Chemistry • Research and Development

Industries

Research

Resumes

Resumes

Rameshbabu Boga Photo 1

Founder And President

View page
Location:
750 Dalrymple Rd, Atlanta, GA 30328
Industry:
Research
Work:
Bogar Laboratories
Founder and President

Kimberly-Clark Sep 2001 - Jul 2007
Senior Research Scientist

Diagnostic Systems Laboratories Oct 1999 - Aug 2001
Director

Medical College of Wisconsin Jul 1995 - Sep 1999
Assistant Professor and Postdoctoral Fellow

University of Michigan Medical School Oct 1993 - Jun 1995
Postdoctoral Associate
Education:
Kyoto University 1988 - 1990
Indian Institute of Technology, Madras 1984 - 1990
Doctorates, Doctor of Philosophy, Organic Chemistry
Kyoto University 1978 - 1984
Skills:
Organic Chemistry
Technology Scouting
Technology Transfer
Commercialization
R&D
Biochemistry
Biotechnology
Drug Discovery
Medicinal Chemistry
Protein Purification
Pharmaceutical Industry
Elisa
Chemistry
Research and Development

Business Records

Name / Title
Company / Classification
Phones & Addresses
Rameshbabu Boga
Principal
BOGAR LABORATORIES LLC
Business Services at Non-Commercial Site · Commercial Physical Research
10030 Carrington Ln, Alpharetta, GA 30022
(678) 393-9015

Publications

Us Patents

Enhanced Diffraction-Based Biosensor Devices

View page
US Patent:
7091049, Aug 15, 2006
Filed:
Jun 26, 2002
Appl. No.:
10/180219
Inventors:
Rameshbabu Boga - Roswell GA, US
Chibueze Obinna Chidebelu-Eze - Atlanta GA, US
Rosann M. Kaylor - Cumming GA, US
Xuedong Song - Roswell GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
G01N 33/543
US Classification:
436518, 422 8205, 422 8208, 422 8211, 435 5, 435 6, 435 72, 435 721, 435 732, 435 734, 435 737, 4352872, 4352887, 435808, 435 731, 436164, 436172, 436513, 436524, 436525, 436527, 436531, 436805, 436815, 436816, 436817
Abstract:
An enhanced diffraction based biosensor system and method are provided for detecting an analyte of interest in a test medium. The system incorporates at least one additional detection tag substance with the analyte of interest, the tag emitting a measurable parameter that is different from optical diffraction characteristics of the analyte. The biosensor may be a “fluoroptical” system wherein the detection tag is a fluorescence emitting substance, including fluorescent-labeled diffraction enhancing elements. The enhanced diffraction biosensor system may determine the presence of analytes in biological fluids both qualitatively and quantitatively.

Self-Contained Swab-Based Diagnostic Systems

View page
US Patent:
7098040, Aug 29, 2006
Filed:
Dec 23, 2003
Appl. No.:
10/744235
Inventors:
Rosann Marie Matthews Kaylor - Cumming GA, US
RameshBabu Boga - Roswell GA, US
Kaiyuan Yang - Cumming GA, US
David Samuel Cohen - Alpharetta GA, US
Herb Velazquez - Neenah WI, US
Amanda Lee O'Connor - Appleton WI, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
G01N 33/558
US Classification:
436514, 604 1, 604 3, 422 50, 422 55, 422 56, 422 57, 422 58, 422 61, 422101, 4352871, 4352872, 4352881, 435810, 435970, 436 63, 436518, 436805, 436810
Abstract:
A diagnostic test unit is provided. The test unit comprises a stem having a first end and a second end, the stem defining at least one flow channel extending between the first end and the second end. A swab is disposed at the first end of the stem, the swab being configured to collect a test sample derived from a biological source that is suspected of containing an analyte. The test unit also comprises a fluid chamber configured to contain a fluid, wherein the fluid chamber is in fluid communication with the swab via the flow channel. The test unit also comprises a rupturable seal that inhibits leakage of the fluid from the fluid chamber prior to use, and an assay for detecting the presence or absence of the analyte. The assay is in fluid communication with the swab, the flow channel, and the fluid chamber.

Visual Indicating Device For Bad Breath

View page
US Patent:
7413550, Aug 19, 2008
Filed:
Oct 16, 2003
Appl. No.:
10/687270
Inventors:
John Gavin MacDonald - Decatur GA, US
RameshBabu Boga - Alpharetta GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61B 5/02
US Classification:
600532, 600300
Abstract:
The invention provides a breath testing device which includes a visual indicating agent which changes color in the presence of an odor associated with bad breath, such as sulfur and ammonia odors. An example of the visual indicating agent is 4,4′-bis(dimethylamino)-benzhydrol (Michler's hydrol or BDMB) and related dyes having a similar chemical structure. The indicating agent is applied to a substrate which is then inserted into a tube or straw, or which covers one end of a straw. When a user with bad breath blows into the tube or straw, the indicating agent will change color. The breath testing devices provide a quick and affordable means for a user to test their breath, and they may be packaged in discreet, pocket-sized dispensers which can be carried in a pocket or purse.

Antibody Pair Screening Methods

View page
US Patent:
7514226, Apr 7, 2009
Filed:
Jul 26, 2005
Appl. No.:
11/189461
Inventors:
RameshBabu Boga - Roswell GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
G01N 33/53
US Classification:
435 71, 435 72, 435 791, 435 792, 436512, 436513
Abstract:
The invention provides methods for identifying antibody preparations that can form a pair of antibodies that optimally detect a target antigen, for example, in a sandwich immunoassay. These methods provide high affinity and epitope-specific antibodies.

One-Step Enzymatic And Amine Detection Technique

View page
US Patent:
7521226, Apr 21, 2009
Filed:
Jun 30, 2004
Appl. No.:
10/881010
Inventors:
Xuedong Song - Roswell GA, US
RameshBabu Boga - Roswell GA, US
Chibueze Obi Chidebelu-Eze - Atlanta GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
C12M 1/34
US Classification:
4352871
Abstract:
A technique for detecting the presence or quantity of an enzyme (or enzyme inhibitor) and/or an amine within a test sample is provided. For example, in one embodiment, a diagnostic test kit is employed that utilizes reactive complexes that each includes a substrate joined (e. g. , covalently bonded, physically adsorbed, etc. ) to a reporter and a separation species. Upon contacting the reactive complexes, enzymes may cleave the substrate and release the reporter. Moreover, the test kit may also employ a chemichromic dye, i. e. , a dye that exhibits a detectable color change upon chemical reaction with one or more functional groups, such as amino groups. The signal generated (directly or indirectly) by the reporter and chemichromic dye may then be used to indicate the presence or quantity of an enzyme (or enzyme inhibitor) and amine, respectively, within the test sample.

Method And Device For Detecting Ammonia Odors And Helicobacter Pylori Urease Infection

View page
US Patent:
7582485, Sep 1, 2009
Filed:
Oct 16, 2003
Appl. No.:
10/687327
Inventors:
RameshBabu Boga - Roswell GA, US
John Gavin MacDonald - Decatur GA, US
Assignee:
Kimberly-Clark Worldride, Inc. - Neenah WI
International Classification:
G01N 33/53
G01N 33/00
US Classification:
436113, 435 71, 435 12, 422 61, 600532
Abstract:
The invention provides a breath testing device which visually indicates the presence of ammonia in a patient's breath, in particular ammonia from urease infection. The breath testing device comprises a visual indicating agent which changes color in response to ammonia odors, such as 4,4′-bis(dimethylamino)-benzhydrol (Michler's hydrol or BDMB), pararosaniline base and alpha-naphtholbenzein. The indicating agent is applied to a substrate which is then inserted into a tube or straw, which can be attached to the inlet of a breath collection balloon. When the patient blows into the tube or straw, the indicating agent will change color if it detects levels of ammonia which are consistent with urease infection.

Personal Care Products With Visual Indicator Of Vaginitis

View page
US Patent:
7592020, Sep 22, 2009
Filed:
Oct 8, 2004
Appl. No.:
10/961676
Inventors:
RameshBabu Boga - Roswell GA, US
John Gavin MacDonald - Decatur GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61F 13/00
A61K 9/70
US Classification:
424443, 424400, 424430, 424445
Abstract:
There is provided a personal care product having a body side liner, a baffle and an indicator strip with two ends. The indicator has an amine sensitive dye near at least one end. The indicator extends from the target area just below the liner to just above the baffle such that the dye deposit is visible to an unaided eye. The dye changes color in the presence of amines which are characteristic of infection, thus alerting the user to the possibility of infection. Such an indicator placed in a feminine hygiene pad, for example, may be useful in the diagnosis of vaginitis.

Identification Of Compounds For Inhibiting Complexation Of C-Reactive Protein With Fibronectin

View page
US Patent:
7645583, Jan 12, 2010
Filed:
Dec 14, 2005
Appl. No.:
11/302994
Inventors:
RameshBabu Boga - Alpharetta GA, US
Sohail Malik - Athens GA, US
Stephen Quirk - Alpharetta GA, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
G01N 33/53
G01N 33/533
G01N 21/76
US Classification:
435 71, 435 793, 436546, 436172, 436815
Abstract:
Disclosed are screening processes for identification of compounds that may inhibit complex formation between C-reactive protein and fibronectin. Compounds identified by the disclosed methods may be utilized to inhibit the target analytes that are known to occur during skin aging as well as during the course of several diseases. Accordingly, inhibitory compounds identified by the disclosed methods may be utilized to prevent and treat damaged tissue, inflammatory conditions, cardiovascular conditions, renal conditions, periodontal conditions and obesity, among other conditions. For example, the compounds identified by the disclosed methods may be utilized to treat tissue that has suffered trauma, e. g. , burns or wounds, as well as tissue that is inflamed due to any of several causes. The disclosed compounds may also be utilized to improve the accuracy of assays designed to assess CRP or Fn levels in a sample, for instance in a plasma sample, as a risk assessment tool in certain medical conditions and to discover new treatments.
Rameshbabu B Boga from Atlanta, GA, age ~63 Get Report